What Does QuidelOrtho Do?

Total employees7000
HeadquartersSan Diego
Founded1979

QuidelOrtho Corporation unites the strengths of Quidel Corporation and Ortho Clinical Diagnostics, forming a global leader in the development and manufacturing of innovative in vitro diagnostic solutions. The company provides a broad range of products that aid in the diagnosis and monitoring of various diseases and health conditions, from infectious diseases like influenza and COVID-19 to cardiometabolic, autoimmune, and women's health conditions, as well as solutions for blood typing and screening. QuidelOrtho is committed to improving patient outcomes and healthcare efficiency worldwide through reliable and accessible diagnostic testing.

Where Is QuidelOrtho's Headquarters?

HQ Function

Serves as the central hub for corporate governance, strategic planning, research and development leadership, and global operational oversight for QuidelOrtho.

Notable Features:

State-of-the-art R&D labs and corporate offices designed to foster collaboration and innovation. Facilities are modern and aligned with biotech industry standards.

Work Culture:

Emphasizes innovation, collaboration, customer focus, and a commitment to quality in delivering diagnostic solutions. Employees are driven by the impact of their work on global health.

HQ Significance:

The San Diego location leverages the region's rich talent pool in life sciences and its ecosystem of research institutions and biotech companies, fostering innovation and strategic partnerships.

Values Reflected in HQ: The headquarters reflects QuidelOrtho's commitment to scientific excellence, innovation in diagnostics, and operational efficiency in serving global healthcare needs.

Location:

QuidelOrtho supports global healthcare needs through a worldwide network of manufacturing sites, R&D centers, commercial offices, and distribution partners. The company's operations span North America, Europe, Asia-Pacific, Latin America, and other key regions, ensuring the development, production, and delivery of diagnostic solutions to laboratories, hospitals, and point-of-care settings across more than 130 countries and territories. Functions supported globally include sales and marketing, customer service and technical support, supply chain and logistics, regulatory affairs, and clinical research.

Street Address:

9975 Summers Ridge Road

City:

San Diego

State/Province:

California

Country:

USA

Where Else Does QuidelOrtho Operate Around the World?

Raritan, New Jersey/USA

Address: 1001 US-202, Raritan, NJ 08869, USA

Key hub for Americas operations, R&D for specific diagnostic platforms, and manufacturing. Former headquarters of Ortho Clinical Diagnostics.

Pencoed, Wales/UK

Address: Ortho Clinical Diagnostics, Pencoed Technology Park, Pencoed, Bridgend CF35 5PZ, United Kingdom

Primary manufacturing and distribution center for Europe, Middle East, and Africa (EMEA), supporting a wide range of diagnostic products.

Athens, Ohio/USA

Address: 3420 West State Street, Athens, OH 45701, USA

Supports high-volume manufacturing of diagnostic tests for the North American market and global distribution.

Buying Intent Signals for QuidelOrtho

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading QuidelOrtho? Meet the Executive Team

As of April 2025, QuidelOrtho' leadership includes:

Douglas Bryant - President and Chief Executive Officer
Joseph Busky - Chief Financial Officer (retiring July 2024)
Bryan L. Giraudo - Chief Financial Officer (effective July 29, 2024)
William H. Rodgers, Ph.D. - Executive Vice President, Chief Research and Development Officer
Mary A. Malarkey, Ph.D. - Executive Vice President, Chief Regulatory and Quality Officer
Michael C. Abney, Ph.D. - Chief Operations Officer
Robert Bujarski - President, Commercial Operations
Michelle M. Greene - Executive Vice President, Chief Human Resources Officer
Jean M. Fahy - Executive Vice President, General Counsel and Chief Compliance Officer

Who's Investing in QuidelOrtho?

QuidelOrtho has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
State Street Corporation
Price (T. Rowe) Associates Inc.
FMR LLC (Fidelity Management & Research)

What Leadership Changes Has QuidelOrtho Seen Recently?

Hire4
Exits1

QuidelOrtho has actively shaped its executive team over the past 12 months, with key appointments in operations, legal, commercial operations, and an upcoming transition in finance, underscoring its commitment to strategic leadership and operational excellence following its merger.

Departures

Joseph Busky, Joseph Busky announced retirement, effective end of July 2024.

New Appointments:

Bryan L. Giraudo, Bryan L. Giraudo appointed as new CFO, effective July 29, 2024.
Robert Bujarski, Robert Bujarski appointed as President, Commercial Operations.
Jean M. Fahy, Jean M. Fahy appointed as EVP, General Counsel and Chief Compliance Officer.
Michael C. Abney, Ph.D., Michael C. Abney, Ph.D., appointed as Chief Operations Officer.

What Technology (Tech Stack) Is Used byQuidelOrtho?

Discover the tools QuidelOrtho uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

QuidelOrtho Email Formats and Examples

QuidelOrtho commonly uses the email format first.last@quidelortho.com. Variations might exist, but this is a prevalent structure for corporate communications.

first.last@quidelortho.com

Format

jane.doe@quidelortho.com

Example

85%

Success rate

What's the Latest News About QuidelOrtho?

QuidelOrtho Press ReleaseJune 3, 2024

QuidelOrtho Announces Retirement of Chief Financial Officer Joseph Busky and Appointment of Bryan L. Giraudo as Successor

QuidelOrtho Corporation announced that Joseph Busky, Chief Financial Officer, will retire from the Company at the end of July 2024. Bryan L. Giraudo has been appointed to succeed Mr. Busky as Chief Financial Officer, effective July 29, 2024....more

QuidelOrtho Press ReleaseMay 7, 2024

QuidelOrtho Reports First Quarter 2024 Financial Results

QuidelOrtho Corporation reported its financial results for the first quarter ended March 31, 2024, detailing revenue, earnings, and updates on its product segments and outlook....more

QuidelOrtho Press ReleaseApril 23, 2024

QuidelOrtho Showcases Latest Innovations in Clinical Chemistry and Point-of-Care Diagnostics at ECCMID 2024

QuidelOrtho highlighted its advanced diagnostic solutions, including new assays and instrument platforms, at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2024, emphasizing its commitment to addressing evolving healthcare challenges....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including QuidelOrtho, are just a search away.